InMed Pharmaceuticals (INM) has released an update.
InMed Pharmaceuticals has filed an international patent application for INM-901, a small molecule drug candidate aimed at treating neurodegenerative diseases like Alzheimer’s. The drug shows promise in reducing neuroinflammation and improving cognitive function, positioning it as a potentially significant advancement in treating these conditions.
For further insights into INM stock, check out TipRanks’ Stock Analysis page.
